![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 33, 23296-23304, August 13, 1999
From the Structural Biology Unit, National Institute of Immunology,
Aruna Asaf Ali Marg, New Delhi 110 067
The structural requirements for the antibacterial
activity of a pseudosymmetric 13-residue peptide, tritrypticin, were
analyzed by combining pattern recognition in protein structures, the
structure-activity knowledge-base, and circular dichroism. The
structure-activity analysis, based on various deletion analogs, led to
the identification of two minimal functional peptides, which by
themselves exhibit adequate antibacterial activity against
Escherichia coli and Salmonella typhimurium.
The common features between these two peptides are that they both share
an aromatic-proline-aromatic (ArProAr) sequence motif, and their
sequences are retro with respect to one another. The pattern searches
in protein structure data base using the ArProAr motif led to the
identification of two distinct conformational clusters, namely
polyproline type II and The survival of all living organisms necessitates a rapid and
effective host defense against invading pathogens. The higher organisms
that have arrived much later in a world inhabited by prokaryotes
developed many host defense mechanisms, including gene-encoded
antimicrobial peptides to face the challenge of these pathogens (1, 2).
While the antimicrobial peptides serve as one of the first line of
defense against pathogens in vertebrates, they represent the major
component of the immune response in invertebrates (3, 4). They are
generally localized at specific sites that are exposed to microbial
invasion. A class of antibacterial peptides called cathelicidins, which
are synthesized as larger precursor molecules in bone marrow, are thus
active in polymorphonuclear leukocytes (5). Several members of
cathelicidin family have been characterized and include CAP18 from
rabbit granulocyte (6); p15 from rabbit polymorphonuclear leukocyte
(7); bac5, indolicidin, and cyclic dodecapeptide from bovine
neutrophils (8-10); and C12 from porcine bone marrow (11). The shared
N-terminal domain in all these precursor molecules is homologous to
cathelin, a known host defense molecule of innate immune response (11). A part of the C-terminal domain varying in length from 13 to 30 residues and having no homology among different members of
cathelicidins has antimicrobial activity. Tritrypticin is one such
13-residue tryptophan-rich bactericidal peptide derived from C12
(12).
The inherent genetic plasticity on one hand and the ability to adapt to
challenging environments on the other have led to the development of
antibiotic resistance by many microorganisms (2). The gene-encoded
antimicrobial peptides show in vitro activities against
microorganisms resistant to conventional antibiotics (2, 13) and could
provide impressive design templates for developing potent
anti-infectious agents. The structure and mechanism of action of
tritrypticin were, therefore, undertaken by a knowledge-based approach
involving analysis of conformational patterns in homologous sequences
under the experimentally derived structural constraints (14). Here we
report the functionally relevant structural features of tritrypticin
and shed light on the possible mechanisms associated with its activity.
Materials--
4-Hydroxymethyl phenoxymethyl polystyrene resin,
solvents, and reagents used for synthesis were supplied by Applied
Biosystems Inc. Fmoc1 amino
acid derivatives were procured from Novabiochem and Bachem Feinchemikalein AG. (Bubendorf, Switzerland). Trifluoroacetic acid,
1,2-ethanedithiol, and thioanisole for cleavage were procured from
Sigma. Phenol crystals (analytical reagent) and diethyl ether (analytical reagent) were purchased from S. D. Fine Chem. Ltd. (Boisar, India). High performance liquid chromatography grade acetonitrile was obtained from Merck.
The Gram-negative bacterial strains Salmonella typhimurium
3261 PNP2 Gro A mutant and Escherichia coli BL21( Peptide Synthesis, Purification, and
Characterization--
Tritrypticin and its analogs were synthesized by
solid phase method using an automated peptide synthesizer Model 431A
(Applied Biosystems Inc.) employing standard Fmoc methodology. The
peptides were cleaved from the resin by treatment with trifluoroacetic acid/thioanisole/phenol/water/1,2-ethanedithiol in ratio as recommended by Applied Biosystems Inc. The crude peptides were purified using C-18
column (Deltapak-100Å, 15 µm spherical, 19 × 300 mm, Waters), and peptide purity was verified using C-18 analytical column
(Deltapak-300Å, 15 µm, spherical, 7.8 × 300 mm, Waters).
Elution of the peptides was accomplished with a linear gradient from 15 to 80% acetonitrile containing 0.1%trifluoroacetic acid over 30 min.
Characterization was performed by molecular mass determination using
single Quadruple mass analyzer (Fisons Instruments, Altrincham, UK).
Antibacterial Assay--
The radial diffusion assay was
performed using double-layered agarose as described by Lehrer et
al. (15) with slight modification. Bacteria were grown overnight
for 18 h at 37 °C in 10 ml of full strength (3% w/v) TSB; 10 µl of this culture was inoculated into 10 ml of fresh TSB and
incubated for an additional 3 h at 37 °C to obtain
midlogarithmic phase organisms. About 1 × 106 cells
were then mixed with 1% agarose in 10 mM sodium phosphate buffer, pH 7.4, containing 0.02% Tween 20 and 0.03% TSB. The mixture was poured into round Petri plates after rapidly dispersing, and a
5-µl peptide sample was placed in each well made in the agarose and
then incubated at 37 °C for 3 h. The overlay agar containing 1% agarose in 10 mM sodium phosphate buffer, pH 7.4, and
3% TSB was then poured over it and further incubated at 37 °C for
18-24 h. The diameter of the clear zone surrounding the well was
measured for the quantitation of inhibitory activities.
Circular Dichroism--
The circular dichroism (CD) experiments
were carried out on a JASCO 710 spectropolarimeter with 1.0 nm
bandwidth at 0.1-nm resolution and 1 s response time using a 10-mm
path-length cell. Typically, 20 scans at a speed of 200 nm/min were
accumulated at 10 °C and averaged. The peptide concentrations used
were 10 µM in water. Results were expressed as mean
residue molar ellipticity in deg cm2/dmol.
Computer Modeling--
BLAST program (16) on Internet was used
for sequence searches in the Brookhaven protein data bank (PDB) (17).
The BIOSYM software INSIGHTII (Biosym Technologies) was used on
INDIGO2 workstation (Silicon Graphics) for model building,
analysis, and display of structural data. Template-based peptide
modeling was carried out using the HOMOLOGY module based on the
coordinates of individual homologous sequences in the corresponding PDB
files. The models were refined in AMBER force field (18) using energy minimization. Distance-dependent dielectric constant was
used, and no cross-term energies were included.
Identification of the Smallest Active Analog(s) of
Tritrypticin--
The antibacterial activity of tritrypticin (SN13)
against S. typhimurium and E. coli, determined by
radial diffusion assay, is shown in Fig.
1. The dose-dependent
increase in the antibacterial activity of SN13 was evident in both the
cases, although it is slightly more active against E. coli
than S. typhimurium. These curves were used as reference for
all the subsequent experiments designed to compare activities of the
tritrypticin analogs. Activities of the analogs were assayed at 5 and
50 nmol as both these quantities fall into the linear region of the
dose-dependent activity curve. It was observed that the
comparative activities of the analogs inferred on the basis of
inhibition zone area at 5 and 50 nmol are consistent with each other;
therefore, data corresponding only to 5 nmol are given in subsequent
comparisons of the activities of tritrypticin analogs.
The shortest active fragment of SN13 was identified by synthesizing
various deletion analogs and subjecting them to the antibacterial activity assay. Table I shows different
analogs identified by their sequences and an internally consistent code
defining each of these peptides. Activity of the peptide is given as
the inhibition zone area at the peptide dose of 5 nmol as well as the
relative activity (%) with reference to SN13. Behavior of various
deletion analogs of tritrypticin appeared similar in the two bacterial strains. As shown in Table I, an analog with deletion of Val-1 (SN12)
had activity comparable with that of SN13. Subsequent N-terminal deletions showed progressive decrease in the activity except in case of
SN10, which seemed to show drastic reduction in activity to about 22%
for S. typhimurium and 30% for E. coli. Further
deletion of another residue (Phe-4) led to regaining of the activity
(74% for S. typhimurium and 94% for E. coli) in
case of SN9. SN8 becomes the smallest active fragment of tritrypticin
if those analogs with activity more than 50% of the native
tritrypticin were defined as active.
The sequence of SN13 is somewhat symmetric, and deletion of Val-1 does
not affect its activity. Therefore, it was expected that the deletion
of Val-1 and Leu-11 in SN13, which makes it a perfectly symmetric
peptide (SYM11) in terms of amino acid sequence, could also be active.
It turned out that SYM11 was more active than the native peptide (Table
I). Correspondingly, CT7, an analog of SN8 with deletion of Leu-6 was
also showing comparatively more activity. The corresponding inversely
equivalent N-terminal peptide (NT7) also showed high antibacterial
activity (Table I). Thus, NT7 and CT7 are the minimal bioactive analogs
of tritrypticin.
Search for Conformational Patterns Associated with the Minimal
Bioactive Analogs--
The sequences of NT7 and CT7 are related,
considering that they essentially represent two halves of a symmetric
larger peptide. The design of their sequences is such that the two
peptides are mirror images of each other. They both are made up of a
central tripeptide sequence motif, aromatic-proline-aromatic (ArProAr), with two cationic residues on one side and two tryptophans on the
other. The conformational preferences of the ArProAr sequence motif,
common among these two almost equally active seven-residue peptides,
were analyzed in PDB using XXArProArXX as the
search sequence, where X is any amino acid. The search using
BLAST led to the identification of 45 unique 7-residue sequences
incorporating this motif.
The least square superimpositions of these seven-residue segments led
to the identification of conformational clusters showing two distinct
patterns. The backbone conformations of these segments were
superimposed using the coordinates from the corresponding protein
structures in PDB for each of the two groups. Group I consisted of 15 different segments having backbone torsion angles approximately
corresponding to polyproline type II (PP II) conformation. The central
five residues of these structures could be superimposed such that the
corresponding C
The backbone torsion angles for group I and II were analyzed by help of
the Ramachandran plot (Fig. 3). The
The structural models for CT7 and NT7 were built using the template
coordinates of segments in group I and II, respectively. The van der
Waals surface drawings of these models, color-coded to indicate the
hydropathy nature of the residues, are shown in Fig.
4, A and B,
respectively. There was a distinct clustering of the aromatic residues
and the cationic residues in both these groups. However, the clustering
was more prominent in group I, which forms PP II structure, compared
with group II, which forms Structure-Function Analysis of Minimal Bioactive Analogs--
The
solution structures of the minimal bioactive analogs were investigated.
The CD profiles of NT7 and CT7 in aqueous medium are shown in Fig.
5. The profile in the 250-190-nm range
suggested that the two analogs each have a definitive, although very
different structure in solution. CT7 showed a mean residue molar
ellipticity minima at 206 nm, characteristic of the PP II conformation.
NT7, which has mirroring sequence with respect to CT7, showed a maximum at 212 nm that corresponds to Structure-Function Analysis of Tritrypticin--
Antibacterial
activity of native tritrypticin was compared with that of different
deletion analogs of SN13 to delineate the functional role of different
N- and C-terminal residues (Table I and Fig.
6A). As described earlier,
deletion of a pair of N-terminal cationic residues (SN10) led to
drastic loss in activity. Similarly, NT9, the peptide arising from
deletion of the C-terminal cationic residues (RRFPWWWPF) also led to
significant loss in activity. The deletion of Phe-1 in SN10 (leading to
SN9) resulted in enhancement of activity compared with that of SN10.
Substitution of all the arginines to lysines in the symmetric peptide
SYM11 led to an analog (SYM11KK) with activity comparable with that of
SYM11 and about 140% that of native tritrypticin.
The CD profile of SN13 is shown in Fig. 6B. The positive
mean residue molar ellipticity at 212 nm suggests a characteristic
The SN13 analogs, in which the tryptophan residues were substituted by
either an aromatic residue (tyrosine) or a nonaromatic residue
(serine), were analyzed to characterize the role of tryptophans in
antibacterial activity and structural integrity. All the three tyrosine
substituted analogs showed about 25% enhancement in the activity (Fig.
7A). The analogs with
nonaromatic substitution at any of the three positions were marginally
more active than those substituted by tyrosine. The comparisons of the
CD profiles of tyrosine- and serine-substituted analogs with that of
SN13 are shown in Fig. 7, B and C, respectively.
The substitution of Trp-8 Tritrypticin belongs to the class of cationic antibacterial
peptides. Generally, the cationic peptides have two distinguishing features. These molecules are amphipathic, and they carry a net positive charge of at least +2 (2). The cationic peptide antibiotics are potent candidates for countering antibiotic resistance developed by
the microbes against established antibiotics. Although there are
inherent difficulties in exploiting peptidyl molecules as drug
candidates (20), they provide ideal templates for peptidomimetic design
with enhanced half-life and potency while maintaining structure and
specificity. The cationic antibacterial peptides show pronounced structural heterogeneity. The three-dimensional structures of at least
one member of three different families of peptidyl antibiotics have
been determined (21-25). As the functional specificity and mechanism
of killing are obviously dependent on the three-dimensional structure
and chemical nature of the peptide, diverse families of cationic
antibacterial peptides are unlikely to adopt a common mechanism of
action. The structural insights gained in the functional context could
make tritrypticin among the most suitable candidates for peptidomimetic design.
Tritrypticin is a pseudosymmetric molecule. Although it was suggested
that the 13-residue tritrypticin is a processed antibiotic (12),
alignment of the precursor sequence with other cathelicidin precursors
implies that Val-1 in this sequence should correspond to the elastase
cleavage site (11). Therefore, Val-1 in tritrypticin probably has no
functional role. The comparison of SN12 and SN13 activities confirmed
this interpretation. A symmetric analog (SYM11) also shows enhanced
antibacterial activity. Besides, NT7 and CT7 are both active and may
correspond to two independent minimal functional domains. This would
imply that the symmetric composite peptide SYM11 or the native SN13 are
naturally designed to enhance activity by some sort of duplication. NT7
and CT7 are not entirely unrelated. Their sequences are retro with
respect to each other. Another common feature of these two minimal
bioactive peptides is the ArProAr motif incorporated within their
sequences. A couple of other peptides having similar sequence features
have also been shown to possess definitive structural folds (26, 27).
Considering that both NT7 and CT7 are equally active, this common motif
was critical in deriving the structural and functional features
associated with their antibacterial activities.
Pattern recognition in the protein structure data base led to the
identification of two distinct conformational motifs, namely PP II and
Two structural motifs derived from the patterns in protein structures
are consistent with the solution conformations of the two minimal
bioactive analogs. NT7, which exhibits One of the characteristic features of the CD profiles of tritrypticin
analogs is the dichroic signal at about 225 nm, which is expected to
arise because of the conformational environment of the tryptophan
residue. The asymmetric indole derivative of the tryptophan side chain
could lead to either positive or negative circular dichroic rotation
depending on the backbone conformation in the immediate neighboring
residues (19). All the analogs discussed in the present study have
multiple tryptophan residues. It is evident that in some of them the
mean residue molar ellipticity is positive, and in some others it is
negative. However, there is a direct correlation of the sign of
ellipticity at 225 nm with secondary structural characteristics. All
the peptides with negative molar ellipticity at 225 nm have a distinct
positive signal at 212 nm corresponding to Tritrypticin has a definitive structure in solution. There is a clear
Tritrypticin apparently undergoes a conformational transition while
approaching the membrane receptor. The majority of the small bioactive
peptides, which are not constrained through an intramolecular disulfide
bridge, undergo a transition from an unstructured to a structured
active form in the vicinity of the receptor (14). A disorder-order
transition is involved in the activation of such peptides in most cases
where the peptide does not indicate any preferred conformation.
Tritrypticin is unique in that it adopts a well defined type III
The precise mechanism of bacterial killing by tritrypticin is not
known. A diverse array of mechanisms by which other peptidyl antibiotics attack the bacterial cell have been proposed. Many cationic
antibiotic peptides are suggested to be membrane-active and assemble
forming channels (34-35). Alternatively, certain peptides cluster at
the membrane surface and cause a cooperative permeabilization by the
carpet effect (36). On the other hand, apidaecins function through a
receptor-activated nonpore-forming mechanism involving stereospecificity (37). The bactenecins are suggested to cause loss of
macromolecular synthesis ability (38). The nonlytic PR-39 kills
bacteria by interrupting both DNA and protein synthesis (39). The DNA
binding property of tachyplesin I has also been implicated in the
antibiotic activity (40). The observed differences in the mechanism for
bacterial killing appear to be consistent with the structural diversity
among these molecules. However, the initial event common to all the
cationic peptides is the binding of positively charged residues to the
negatively charged molecules exposed at the target cell surface. The
peptide antibiotics show differential activities against different
bacterial strains, which may be related to the differences in the
composition of the cell surface molecules. The tritrypticin and its
minimal functional domains exhibit activity against at least two
different Gram-negative bacteria. It does not necessarily imply that it
would similarly work against any bacterial strain. The amphipathic
structural design may be relevant for the specificity of tritrypticin.
It may be achieved by clustering of the hydrophobic residues and cationic residues on its either side, appropriately distanced as in any
PP II structure, such that it can match a complementary site on the
receptor. Both the hydrophobic clustering and the electrostatic
interactions accompanied by the relative flexibility in the peptide
molecule would provide certain leeway within this specificity.
In summary, tritrypticin has predominantly We thank Drs. C. Shaha and N. Gautham for
useful suggestions.
*
This work was supported by the Department of Science and
Technology (with an extra-mural grant to D. M. S.) and the Department of Biotechnology (with the funds provided to the National Institute of
Immunology) of the government of India.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The abbreviations used are:
Fmoc, N-(9-fluorenyl)methoxycarbonyl;
TSB, tryptic soy broth;
PDB, protein data bank;
ArProAr, aromatic-proline-aromatic;
PP II, polyproline type II.
Structure-Function Analysis of Tritrypticin, an Antibacterial
Peptide of Innate Immune Origin*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-turn, which correspond to the observed
solution structures of the two minimal functional analogs. The role of
different residues in structure and function of tritrypticin was
delineated by analyzing antibacterial activity and circular dichroism
spectra of various designed analogs. Three main results arise from this
study. First, the ArProAr sequence motif in proteins has definitive
conformational features associated with it. Second, the two minimal
bioactive domains of tritrypticin have entirely different structures
while having equivalent activities. Third, tritrypticin has a
-turn
conformation in solution, but the functionally relevant conformation of
this gene-encoded peptide antibiotic may be an extended polyproline
type II.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
D3) were
used for radial diffusion assay. Agarose I (Biotechnology grade) was obtained from Amresco, and tryptic soy broth (TSB) was from Himedia Laboratories Pvt. Ltd. (Mumbai, India). Tween 20 was purchased from
Aldrich. Sterilized round Petri plates were purchased from Tarsons
(Calcutta, India).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (17K):
[in a new window]
Fig. 1.
Dose-dependent activity curve of
tritrypticin showing antibacterial activity against S. typhimurium and E. coli expressed in terms
of inhibition zone area in the radial diffusion assay.
Comparison of antibacterial activities of the deletion analogs of
tritrypticin
atoms overlap completely (Fig.
2A). On the other hand, group II consisted of 13 segments exhibiting type III
-turn. The residues 3-6 could be superimposed in all these entries such that the
C
atoms overlap in this case as well (Fig.
2B). The remaining 17 sequences were widely distributed such
that they could not be classified into any major conformational
cluster.

View larger version (27K):
[in a new window]
Fig. 2.
The stereoview of the least squares
superimposition of the backbone conformations of seven-residue segments
from the PDB incorporating ArProAr motif, which show PP II conformation
(A) in 15 different cases (group I) and
turn conformations (B) in 13 different cases (group II). The PDB entries from which group I is
derived are 4SBV, 2MEV, 1DLC, 2ACT, 1SLN, 1NHK, 1HLE, 3HMG, 2SBL, 1NAL,
1XAA, 3SC2, 1FGH, 1MMP, and 2CST, and those from which group II is
derived are 1POW, 1ATP, 1MDQ, 1ELT, 9PAP, 1GHS, 1CPC, 2CYP, 2MHB, 1XYZ,
1GFF, 1PRC, and 1SLY.
and
values of overlapping residues of the 7-residue segments in
group II (Fig. 3A) and group I (Fig. 3B) were
indicated on the Ramachandran plot. The residues 3, 4, and 5 in group I
showed clustering around the average
and
values of
75°,
+140° representing PP II conformation, and the residues 4 and 5 in
group II showed clustering around the average
and
values of
60°,
30° representing type III
-turn. Because the
-turn
is stabilized by an hydrogen bond, the spread in the backbone torsion
angles in this case is less than in the case of PP II, which is an
extended conformation. The PP II conformation also extends to the next
residue on either side in majority of the cases among this group.

View larger version (14K):
[in a new window]
Fig. 3.
The conformational clusters corresponding to
ArProAr motif in the protein data bank identified from the Ramachandran
( 
) plot for
turn (A) and PP II (B)
conformations. The residues 4 and 5 in the case of
turn and 3, 4, and 5 in case of PP II have been plotted superimposed with the
allowed regions of the Ramachandran plot.
-turn structure. Also, these clusters are
spaced differently in groups I and II. The average distance between the
center of gravity of the cationic cluster and that of the hydrophobic
cluster was about 10 Å for
-turn structures and about 16 Å for PP
II structures. In case of the other structures, which did not fall into
either of the common patterns, such an obvious segregation could not be
easily defined.

View larger version (53K):
[in a new window]
Fig. 4.
Structural models of CT7 (A)
and NT7 (B) based on group I and group II segments
containing the ArProAr motif from the protein data bank. The van
der Waals surface color-coded with hydropathy property of the side
chains is displayed in each of the 15 models in case of CT7 and 13 models in case of NT7. The color changes from blue to
red while going from highly hydrophilic to highly
hydrophobic residues. Labels are adopted from the PDB code of the
corresponding proteins.
-turn conformation. Both these peptides exhibited a prominent CD signal at around 225 nm, which arises
primarily from the interactions of the aromatic tryptophan residues
(19). This signal showed a negative peak in the case of NT7 but an
opposite, positive and equal peak at the same wavelength for CT7. The
antibacterial activity of NT7 as well as CT7 decreased in the presence
of Mg2+ (data not shown) as in case of tritrypticin (12),
an observation suggested to represent functional measure of the
cationic peptide antibiotics (2).

View larger version (16K):
[in a new window]
Fig. 5.
The CD profiles of the N- and the C-terminal
7-mer peptides, NT7 (RRFPWWW) and CT7 (WWWPFRR), respectively, indicate
that the structural behavior of these peptides is consistent with the
structural features arising from the pattern search.

View larger version (37K):
[in a new window]
Fig. 6.
Antibacterial activity data of various
deletion analogs against S. typhimurium
(A), CD spectra of the N-terminal deletion
analogs (B), and the symmetric analogs
(C) compared with tritrypticin, suggesting that the
terminal cationic residues do not significantly affect the structure
but are critical for activity.
-turn conformation. In addition, there was distinct negative mean
residue molar ellipticity at 225 nm arising from the interaction of the
tryptophan side chain with the backbone involving nearest-neighbor residues. Thus, the predominant structural feature revealed by CD is a
-turn, although there was a small signal at 196 nm corresponding to
an extended conformation. Fig. 6B also shows the comparison of CD profiles of the deletion analogs SN10, SN9, SN8, and NT9 with
that of native SN13. SN10 and NT9, which had negligible antibacterial activity, exhibited an enhanced
-turn signal with corresponding loss
in the PP II component. However, SN9, which had regained activity
compared with SN10 with deletion of N-terminal Phe, appears to exist as
a combination/mixture of
-turn and PP II conformations. A complete
transition of conformation from
-turn in the case of native peptide
to PP II in the case of SN8 was observed with further deletion of a
proline. The CD signal at 225 nm also changed sign in this case. The
symmetric analog, SYM11, has enhanced
-turn character compared with
SN13. Similarly, SYM11KK also exhibited CD profile similar to that of
SYM11 (Fig. 6C). Both these peptides did not exhibit any
minima in the region of 196-206 nm, perhaps indicating that they do
not have any fraction of the structure in either extended or PP II conformation.
Tyr showed a decrease in the
-turn
signal at 212 nm and appearance of a small signal at 206 nm. The 225-nm
signal, however, did not change significantly. The substitution of
Trp-7
Tyr led to more pronounced changes. The
-turn signal at
212 nm completely disappeared, and the signal at 206 nm corresponding
to PP II conformation became very prominent. The 225-nm signal
corresponding to the interaction between tryptophan side chains and the
backbone of aromatic residues in this case is almost negligible. The
Trp-6
Tyr substitution led to the conversion of conformation from
-turn to PP II in every respect. There is a significant negative mean residue molar ellipticity corresponding to PP II, a pronounced positive peak at 225 nm, and absolutely no signal corresponding to the
-turn. Similar but somewhat more prominent changes were observed in
the analogs with serine substitutions for each of the tryptophan
residues.

View larger version (44K):
[in a new window]
Fig. 7.
Antibacterial activity data of the six
different tryptophan-substituted analogs against S. typhimurium (A), CD spectra of Trp
Tyr-substituted analogs
(B), and Trp
Ser-substituted
analogs (C) compared with those of the native
tritrypticin.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-turn, for the ArProAr sequence motif. It can be inferred that the
ArProAr sequence motif has an inherent structural preference for one of
these two conformations. Although linear peptides of this size are
normally observed to have multiple conformational populations in
solution, the present case appears to be different. The structural
motifs associated with the ArProAr sequence motif in PDB appear to have
some additional sequence contraints imposed by the nature of residues
downstream of the ArProAr sequence. The consensus in one of the two
residues on the right side of ArProAr motif is a charged residue for
the group I, which adopts PP II conformation. Similarly, consensus
among the two residues at this position is hydrophobic in group II,
which adopts
-turn conformation. Identification of the
conformational patterns associated with specific sequence signatures is
relevant in the context of protein design rules. The architectural
design of proteins is such that a finite number of structural modules
are used again and again in different contexts and combinations (28,
29). Infinitely diverse overall topologies associated with equally diverse functions seem to have emerged from this clever design. Analyses of many such independent structural modules reveal that it is
possible to define sequence signature of a motif by identifying certain
invariant residues, which occur at equivalent positions in a consensus
manner (30-33). The two structural folds associated with their
respective sequence signatures are the important addition to this
library of structural modules.
-turn conformation, has two
hydrophobic residues following the ArProAr motif, and CT7, which shows
PP II conformation, has two charged residues following the ArProAr
motif, similar to the consensus feature observed in the protein data
base. Both the conformations show clear amphipathic nature with the
segregation of cationic residues and aromatic residues. However, the
distance between these clusters is more in the case of the PP II
conformation compared with the
-turn conformation. This may have
direct implications to achieving complementarity vis à
vis the receptor on the membrane. The ArProAr motif with similar
structural preferences has been characterized in peptides among certain
other contexts as well (26, 27).
-turn. Similarly those
peptides that exhibit positive mean residue molar ellipticity at 225 nm
exhibit PP II structure as indicated by a negative signal at 206 nm.
Thus, the characteristic circular dichroic signal arising from the
aromatic side chain-peptide backbone interactions is also linked with
the two distinct conformational states associated with this motif.
-turn signal, but also, in addition, there is a small minimum
corresponding to an extended structure in the CD profile of the native
peptide. The minima corresponding to the extended structure began to
shift toward PP II and appeared prominently as the residues from the
N-terminal were sequentially deleted. The conformational features of
the individual minimal functional domains of SN13, namely NT7 and CT7,
have direct correlation with the conformation of tritrypticin.
Obviously, the N-terminal domain of tritrypticin, which essentially
corresponds to NT7, can be suggested to have a
-turn-fold, and the
C-terminal domain, which primarily constitutes CT7, can be suggested to
have PP II or extended conformation in the molecule. The three
tryptophan residues, apparently important for structure as well as
activity, are actually shared by both the domains. It is also evident
that the charge and not the nature of the side chain is important for
activity in the case of the terminal cationic residues. SN10 and NT9
may have some shielding effect of the terminal Phe residue while
binding to the relevant membrane receptor, resulting in abnormally low activity. It is clear that the amphipathic nature of the peptide alone
is not adequate for its activity, as the smaller amphipathic analogs
were not active.
-turn conformation in solution. The minimal functional analogs of
tritrypticin, NT7 and CT7, show
-turn conformation and PP II
conformation, respectively, and both are equally active. Many different
single substitution analogs of tritrypticin show enhanced antibacterial
activity accompanied by a change in conformation, from
-turn to PP
II. It can therefore be inferred that the functional activation of
tritrypticin may involve a transition from the solution conformation
constituting a
-turn to the bioactive conformation, which is
predominantly PP II type.
-turn conformation in its
N-terminal region and is designed by duplication to have enhanced
activity involving two independent functional domains. More than half
as active as tritrypticin, these domains are functionally equivalent
but structurally very different from each other. As an initial event in
bacterial killing, tritrypticin apparently undergoes functional
activation through a conformational transition from
-turn to
PP II while specifically binding to the negatively charged receptor
exposed at the target bacterial membrane. The specificity of
tritrypticin binding to the membrane surface may be achieved by the
appropriate juxtaposition of the hydrophobic residues and the cationic
residues so as to match a complementary site on the receptor.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel.: 91 11 610 3799 (ext. 386); Fax: 91 11 616 2125; E-mail: dinakar@nii.res.in.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Barra, D.,
Simmaco, M.,
and Boman, H. G.
(1998)
FEBS Lett.
430,
130-140[CrossRef][Medline]
[Order article via Infotrieve]
2.
Hancock, R. E. W.
(1997)
Lancet
349,
418-422[CrossRef][Medline]
[Order article via Infotrieve]
3.
Boman, H. G.
(1995)
Annu. Rev. Immunol.
13,
61-92[CrossRef][Medline]
[Order article via Infotrieve]
4.
Nicolas, P.,
and Mor, A.
(1995)
Annu. Rev. Microbiol.
49,
277-304[CrossRef][Medline]
[Order article via Infotrieve]
5.
Zanetti, M.,
Gennaro, R.,
and Romeo, D.
(1995)
FEBS Lett.
374,
1-5[CrossRef][Medline]
[Order article via Infotrieve]
6.
Lichtenstein, A. K.,
Ganz, T.,
Nguyen, T.-M.,
Selsted, M. E.,
and Lehrer, R. I.
(1988)
J. Immunol.
140,
2686-2694[Abstract]
7.
Levy, O.,
Weiss, J.,
Zarember, K.,
Ooi, C. E.,
and Elsbach, P.
(1993)
J. Biol. Chem.
268,
6058-6063 8.
Zanetti, M.,
Del Sal, G.,
Storici, P.,
Schneider, C.,
and Romeo, D.
(1993)
J. Biol. Chem.
268,
522-526 9.
Selsted, M. E.,
Novotny, M. J.,
Morris, W. L.,
Tang, Y.-Q.,
Smith, W.,
and Cullor, J. S.
(1992)
J. Biol. Chem.
267,
4292-4295 10.
Storici, P.,
Sal, G. D.,
Schneider, C.,
and Zanetti, M.
(1992)
FEBS Lett.
314,
187-190[CrossRef][Medline]
[Order article via Infotrieve]
11.
Pungercar, J.,
Strukelj, B.,
Kopitar, G.,
Renko, M.,
Lenarcic, B.,
and Turk, F. G. V.
(1993)
FEBS Lett.
336,
284-288[CrossRef][Medline]
[Order article via Infotrieve]
12.
Lawyer, C.,
Pai, S.,
Watabe, M.,
Borgia, P.,
Mashimo, T.,
Eagleton, L.,
and Watabe, K.
(1996)
FEBS Lett.
390,
95-98[CrossRef][Medline]
[Order article via Infotrieve]
13.
Hancock, R. E. W., and Lehrer, R. (1998) 16, 82-88
14.
Gupta, H. M.,
Talwar, G. P.,
and Salunke, D. M.
(1993)
Proteins Struct. Funct. Genet.
16,
48-56
[CrossRef][Medline]
[Order article via Infotrieve] 15.
Lehrer, R. I.,
Rosenman, M.,
Harwig, S. S. S. L.,
Jachson, R.,
and Eisenhauer, P.
(1991)
J. Immunol. Methods
137,
167-173[CrossRef][Medline]
[Order article via Infotrieve]
16.
Altschul, S. F.,
Gish, W.,
Miller, W.,
Myers, E. W.,
and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410[CrossRef][Medline]
[Order article via Infotrieve]
17.
Bernstein, F. C.,
Koetzle, T. F.,
Williams, G. J. B.,
Meyer, E. F., Jr.,
Brice, M. D.,
Rodgers, J. R.,
Kennard, O.,
Shimanouchi, T.,
and Tasumi, M.
(1977)
J. Mol. Biol.
112,
535-542[Medline]
[Order article via Infotrieve]
18.
Weiner, S. J.,
Kollman, P. A.,
Nguyen, D. T.,
and Case, D. A.
(1986)
J. Comput. Chem.
7,
230-252
[CrossRef] 19.
Woody, R. W.
(1985)
in
Circular Dichroism of Peptides in Peptides: Anal. Synth. Biol.
(Hruby, V. J., ed), Vol. 7
, pp. 15-114, Academic Press, Inc., London
20.
Boman, H. G.,
Marsh, J.,
and Goode, J. A.
(1994)
Antimicrobial Peptides, CIBA Foundation Symposium
, Vol. 186
, pp. 1-283, John Wiley & Sons, Inc., New York
21.
Holak, T. A.,
Engstrom, A.,
Kraulis, P. J.,
Lindeberg, G.,
Bennich, H.,
Jones, A.,
Gronenborn, A. M.,
and Clore, G. M.
(1988)
Biochemistry
27,
7620-7629[CrossRef][Medline]
[Order article via Infotrieve]
22.
Gazit, E.,
Miller, I. S.,
Biggin, P. C.,
Sansom, M. S. P.,
and Shai, Y.
(1996)
J. Mol. Biol.
258,
860-870[CrossRef][Medline]
[Order article via Infotrieve]
23.
Terwilliger, T. C.,
and Eisenberg, D.
(1982)
J. Biol. Chem.
257,
6010-6015 24.
Hill, C. P.,
Yee, J.,
Selsted, M. E.,
and Eisenberg, D.
(1991)
Science
251,
1481-1485 25.
Skalicky, J. L.,
Selsted, M. E.,
and Pardi, A.
(1994)
Proteins Struct. Funct. Genet.
20,
52-67
[CrossRef][Medline]
[Order article via Infotrieve] 26.
Yao, J.,
Feher, V. A.,
Espejo, B. F.,
Reymond, M. T.,
Wright, P. E.,
and Dyson, H. J.
(1994)
J. Mol. Biol.
243,
736-753[CrossRef][Medline]
[Order article via Infotrieve]
27.
Kaur, K. J.,
Khurana, S.,
and Salunke, D. M.
(1997)
J. Biol. Chem.
272,
5539-5543 28.
Richardson, J. S.
(1981)
Adv. Protein Chem.
34,
167-339[Medline]
[Order article via Infotrieve]
29.
Efimov, A. V.
(1994)
FEBS Lett.
355,
213-219[Medline]
[Order article via Infotrieve]
30.
Rice, P. A.,
Goldman, A.,
and Steitz, T. A.
(1990)
Proteins Struct. Funct. Genet.
8,
334-340
[CrossRef][Medline]
[Order article via Infotrieve] 31.
Kobe, B.,
and Deisenhofer, J.
(1993)
Nature
366,
751-756[CrossRef][Medline]
[Order article via Infotrieve]
32.
Chavali, G. B.,
Nagpal, S.,
Majumdar, S. S.,
Singh, O.,
and Salunke, D. M.
(1997)
J. Mol. Biol.
272,
731-740[CrossRef][Medline]
[Order article via Infotrieve]
33.
Gupta, H. M.,
and Salunke, D. M.
(1992)
Curr. Sci. (Bangalore)
62,
374-376
34.
Ludkte, S. J.,
He, K.,
Heller, W. T.,
Harroun, T. A.,
Yang, L.,
and Huang, H. W.
(1996)
Biochemistry
35,
13723-13728[CrossRef][Medline]
[Order article via Infotrieve]
35.
Falla, T. J.,
Karunaratne, D. N.,
and Hancock, R. E. W.
(1996)
J. Biol. Chem.
271,
19298-19303 36.
Shai, Y.
(1995)
Trends Biochem. Sci.
20,
460-464[CrossRef][Medline]
[Order article via Infotrieve]
37.
Casteels, P.,
and Tempst, P.
(1994)
Biochem. Biophys. Res. Commun.
199,
339-345[CrossRef][Medline]
[Order article via Infotrieve]
38.
Skerlavaj, B.,
Romeo, D.,
and Gennaro, R.
(1990)
Infect. Immun.
58,
3724-3730 39.
Boman, H. G.,
Agerberth, B.,
and Boman, A.
(1993)
Infect. Immun.
61,
2978-2984 40.
Yonezawa, A.,
Kuwahara, J.,
Fujii, N.,
and Sugiura, Y.
(1992)
Biochemistry
31,
2998-3004[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. J. Kaur, P. Sarkar, S. Nagpal, T. Khan, and D. M. Salunke Structure-function analyses involving palindromic analogs of tritrypticin suggest autonomy of anti-endotoxin and antibacterial activities Protein Sci., March 1, 2008; 17(3): 545 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Kaur, S. Pandey, and D. M. Salunke Design of a functionally equivalent nonglycosylated analog of the glycopeptide antibiotic formaecin I Protein Sci., February 1, 2007; 16(2): 309 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Schibli, L. T. Nguyen, S. D. Kernaghan, O. Rekdal, and H. J. Vogel Structure-Function Analysis of Tritrpticin Analogs: Potential Relationships between Antimicrobial Activities, Model Membrane Interactions, and Their Micelle-Bound NMR Structures Biophys. J., December 15, 2006; 91(12): 4413 - 4426. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagpal, K. J. Kaur, D. Jain, and D. M. Salunke Plasticity in structure and interactions is critical for the action of indolicidin, an antibacterial peptide of innate immune origin Protein Sci., September 1, 2002; 11(9): 2158 - 2167. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||